Según un estudio, una sola dosis de un nuevo fármaco antiviral reduce a la mitad el riesgo de enfermarse de COVID grave
Related Posts
On-Site Genetic Testing for Prostate Cancer Increases Patient Compliance
December 27, 2022
TUESDAY, Dec. 27, 2022 (HealthDay News) -- The implementation of an on-site,...
Medicare May Rethink Premium Hike for Pricey Alzheimer Drug
January 10, 2022
MONDAY, Jan. 10, 2022 (HealthDay News) -- Medicare has been told to reassess a...
Canadian Wildfire Smoke Caused Spikes in Asthma-Related ER Visits Across the U.S.
August 25, 2023
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Smoke from Canadian wildfires sent...